HOME ·

SBP GROUP

SBP GROUP (01177.HK): NDA Accepted for Category 1 Innovative Drug IDH1 Inhibitor TQB3454 for Advanced Biliary Tract Cancer
Tags：
SBP GROUP01177.HKNew Drug Application
2026-07-10
SBP GROUP(01177.HK) will spend HKD 10.05 million to repurchase 1.86 million shares on May 8, 2026
Tags：
SBP GROUP01177.HK
2026-05-09
SBP GROUP(01177.HK) will spend HKD 10.05 million to repurchase 1.85 million shares on May 7, 2026
Tags：
SBP GROUP01177.HK
2026-05-07
SBP GROUP(01177.HK) will spend HKD 10.01 million to repurchase 1.83 million shares on Apr 29, 2026
Tags：
SBP GROUP01177.HKrepurchase
2026-04-29
SBP GROUP(01177.HK) will spend HKD 10.05 million to repurchase 1.81 million shares on Apr 27, 2026
Tags：
SBP GROUP01177.HKrepurchase
2026-04-27
SBP GROUP(01177.HK) will spend HKD 10.09 million to repurchase 1.78 million shares on Apr 24, 2026
Tags：
SBP GROUP01177.HK
2026-04-24
SBP GROUP(01177.HK) will spend HKD 10.05 million to repurchase 1.8 million shares on Apr 23, 2026
Tags：
SBP GROUP01177.HKrepurchase
2026-04-23
SBP GROUP(01177.HK) will spend HKD 10.02 million to repurchase 1.72 million shares on Apr 22, 2026
Tags：
SBP GROUP01177.HKrepurchase
2026-04-22
SBP GROUP(01177.HK) will spend HKD 10.06 million to repurchase 1.73 million shares on Apr 21, 2026
Tags：
SBP GROUP01177.HK
2026-04-21